Andrew Elzinga provides support in litigation and regulatory investigations, within the context of antitrust and competition and intellectual property, and with a focus on the healthcare and life sciences industries. Dr. Elzinga works with attorneys and academic experts to perform economic analyses in all phases of the litigation process, including the submission of expert reports, deposition, and trial.
Selected industry experience
- Biologic drugs, health insurance, and pharmaceuticals
Economic Issues in Assessing Potential and Nascent Competition
Fresenius Kabi USA LLC v. Par Sterile Products LLC et al.
Expectations for Healthcare Mergers During the Pandemic
Healthcare Merger Analysis
Cigna’s Acquisition of Express Scripts